Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Trojano

Showing results (211-220 of 342) with videos related to

Pageof 35
Sort By:
Rehabilitation Psychology|May 18, 2023
Predicting sense of coherence among caregiving partners of persons with multiple sclerosisMarta Bassi, Luca Negri, Sabina Cilia, et al.
Plos One|June 28, 2016
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective StudyEmanuele D'Amico, Carmela Leone, Giusi Graziano, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 5, 2025
The Italian Multiple Sclerosis Register Experience With Cladribine: Impact on Relapses, PIRA, and Treatment Sequencing Strategies EvaluationTommaso Guerra, Massimiliano Copetti, Chiara Zanetta, et al.
The Lancet. Child & Adolescent Health|March 28, 2024
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registriesSifat Sharmin, Izanne Roos, Charles B Malpas, et al.
Annals of Clinical and Translational Neurology|April 25, 2015
Comparative efficacy of switching to natalizumab in active multiple sclerosisTimothy Spelman, Tomas Kalincik, Annie Zhang, et al.
Annals of Neurology|July 3, 2003
Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patientsMehdi Alizadeh, Marie-Claude Babron, Brigitte Birebent, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2025
Multiple sclerosis from onset to secondary progression: a 30-year Italian register studyAurora Zanghì, Massimiliano Copetti, Carlo Avolio, et al.
Journal of Neurology|January 3, 2024
Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS RegistryLorena Lorefice, Ottavia Elena Ferraro, Giuseppe Fenu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2021
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort studyMaria Pia Sormani, Irene Schiavetti, Doriana Landi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 2, 2021
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS RegisterEmanuele D'Amico, Aurora Zanghì, Marzia Romeo, et al.
Pageof 35

Showing results (211-220 of 342) with videos related to

Sort By:
Pageof 35
Rehabilitation Psychology|May 18, 2023
Predicting sense of coherence among caregiving partners of persons with multiple sclerosisMarta Bassi, Luca Negri, Sabina Cilia, et al.
Plos One|June 28, 2016
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective StudyEmanuele D'Amico, Carmela Leone, Giusi Graziano, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 5, 2025
The Italian Multiple Sclerosis Register Experience With Cladribine: Impact on Relapses, PIRA, and Treatment Sequencing Strategies EvaluationTommaso Guerra, Massimiliano Copetti, Chiara Zanetta, et al.
The Lancet. Child & Adolescent Health|March 28, 2024
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registriesSifat Sharmin, Izanne Roos, Charles B Malpas, et al.
Annals of Clinical and Translational Neurology|April 25, 2015
Comparative efficacy of switching to natalizumab in active multiple sclerosisTimothy Spelman, Tomas Kalincik, Annie Zhang, et al.
Annals of Neurology|July 3, 2003
Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patientsMehdi Alizadeh, Marie-Claude Babron, Brigitte Birebent, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2025
Multiple sclerosis from onset to secondary progression: a 30-year Italian register studyAurora Zanghì, Massimiliano Copetti, Carlo Avolio, et al.
Journal of Neurology|January 3, 2024
Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS RegistryLorena Lorefice, Ottavia Elena Ferraro, Giuseppe Fenu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2021
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort studyMaria Pia Sormani, Irene Schiavetti, Doriana Landi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 2, 2021
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS RegisterEmanuele D'Amico, Aurora Zanghì, Marzia Romeo, et al.
Pageof 35